BusinessSymphony Health and comScore Introduce Next Generation Cross-Channel Optimization & Measurement SolutionBy Nasdaq OMXJun 12, 2017, 2:00 PM UTC
BusinessFibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized SclerodermaBy Nasdaq OMXJun 12, 2017, 12:00 PM UTC
BusinessVascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2 Diabetes and Persistent High TriglyceridesBy Nasdaq OMXJun 12, 2017, 11:00 AM UTC
BusinessChromaDex announces an exclusive worldwide patent license and research agreement with The Scripps Research Institute to identify the potential role of NIAGEN® in treating breast cancerBy Nasdaq OMXJun 12, 2017, 10:30 AM UTC
BusinessFibrocell Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXJun 8, 2017, 12:00 PM UTC
BusinessAlder to Present Migraine Prevention Data for Eptinezumab at 59th Annual Scientific Meeting of the American Headache SocietyBy Nasdaq OMXJun 7, 2017, 4:00 PM UTC
BusinessCatalyst Pharmaceuticals to Present at the Jefferies 2017 Healthcare ConferenceBy Nasdaq OMXJun 1, 2017, 12:39 PM UTC
